News

It all began with a protein that shouldn’t be there. In healthy women, α-lactalbumin is a protein produced during lactation, ...
A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...
New study by three Indian American researchers promises replacement of invasive surgical biopsies with blood test ...
Knowable Magazine reports that worm-inspired treatments show promise for metabolic diseases by reducing inflammation and ...
The research looked specifically at blood stem cells, which live in the bone marrow and make different types of blood cells.
Maintaining good overall health is key to living a long life, but we may want to particularly focus on the state of our brain ...
Nearly two-thirds of MS patients showed no signs of disability progression five years after having a stem cell transplant, a ...
On the skin, millions of microbial colonists quietly coexist with their host as microscopic allies that help maintain health ...
Teplizumab offers a completely different approach. Instead of simply replacing insulin, it targets the immune attack that causes type 1 diabetes.
The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.
Months after announcing an M&A deal with AstraZeneca, EsoBiotec has released the first small slice of data on the cell ...
Suddenly feeling old? Evidence now suggests that rather than a long, steady decline, we dramatically age around three ...